Connect with us


Cancer research innovation advancing detection and treatments



Cancer research is continually developing, and the most recent innovations have the potential to revolutionise cancer detection and treatment.

The field has significantly advanced over the last two decades, but there’s always more that can be done.

Technological and pharmaceutical innovations impact research as much as clinical trials do.

“I feel that the more we can do, the more we can have on the back end to help translate to from the bench to the bedside,” Cure Brain Cancer Foundation CEO Lance Kawaguchi recently revealed.

“I’ve pretty much been on a mission the last two years to really try to support collaborations globally, and really try to invest as much as possible in early stage biotechs, but also on the newest innovations, like liquid biopsies, like some of the immunotherapies.”

Johns Hopkins Medical Oncologist Dr. Matthias Holdhoff has been researching in the industry, and has seen how things have quickly evolved in that time – as well as the “targeted therapy” approach required for cancer patients.

“For cancer, it’s not one size fits all,” he outlines. “We are pursuing individualised treatment for patients with cancer.

“We are now thinking more of a disease or pathway-based approach.”

One roadblock in the industry has been obtaining enough data and information to allow these technologies and therapies to be used daily.

“We need clinical trials. And one of the challenges here in the United States or worldwide is the very low percentage of individuals who have aggressive cancers, participating in clinical trials,” Neurosurgeon at Johns Hopkins Dr. Chetan Bettegowda says.

“While there are opportunities, I think we as the oncology community, need to do better with outreach, having these trials available locally and diffusely.

“So that we can allow these novel technologies to be tested rigorously and comprehensively and allow them to reach far more people than they do today.

I think huge initiatives need to be enhanced, in order to allow these technologies to go from just a concept, just an idea into a reality that helps human beings with cancer.”

Continue Reading


Powerful partners look to A.I focused future



Last year, the world was introduced to ChatGPT, a breakthrough AI capability that has taken the tech industry by storm. The potential for this innovative tool to transform the way we interact with machines is truly mind-blowing.

With this in mind, 6clicks, a global leader in governance, risk, and compliance software, has been working with ChatGPT for months to integrate it into their own AI engine, Hailey.

Ant Stevens and Louis Strauss, from 6clicks, are leading this integration effort and are excited to announce that Hailey is now equipped with ChatGPT’s advanced capabilities.

This integration has resulted in a powerful and innovative AI system that can perform amazing tasks. The combination of Hailey’s advanced algorithms and ChatGPT’s natural language processing abilities allow Hailey to understand and respond to users in a way that is intuitive and conversational.

Segment presented by 6clicks.

Continue Reading


Tackling the existing gender gap in the biotech sector



Skilling women researchers and nurturing women CEOs

Today’s society is very advanced – in so many ways.

From the cars people drive, to the way they communicate with one another, to the places people can travel to – and how they can get there.

But unfortunately, gender disparity is still evident for female CEOs, particularly in the Biotech sector.

Most people know that gender inequality still exists in some form, but often no action is taken to change it. With women being underrepresented, it might be having a negative impact on the overall outcomes.

“In order to run a company, one has to be worth more than just their research capabilities, there’s lots of more skills that are necessary,” Dr. Zeenia Kaul from Reheva Biosciences reveals. “During my training as a researcher, I was not necessarily offered an opportunity to learn those skills.

“I had to learn them on job.

“Some of the skills necessary to run a successful biotech startup or business are very different.

“As a scientist, I should be able to read a balance sheet and understand what it means for my business.

“I was very fortunate to have business education that allowed me to get the skillset and have a co-founder who had started companies and expanded them.”

Image: file

Cure Brain Cancer Foundation CEO Lance Kawaguchi reveals a similar tale of not many females being – or becoming CEOs – in the sector.

“When I joined the not-for-profit sector two years ago, I didn’t really see any women CEOs,” Kawaguchi adds. “That’s why I wanted to make sure that all the funds that we raised, are going to be dispersed based off merit, not on gender.”

So, how can change be facilitated, not only in the sector but across the board?

“I want to create an ecosystem, so that the biotechs are provided with the commercial experience of how to do intellectual property (IP) law; how to read a balance sheet when you’re doing a debt deal,” Kawaguchi asserts.

“I find many of the researchers, brilliant as they are, don’t have the finance or the business acumen.

“And that’s one thing I’m trying to provide – not only the funding, but also the support to fill in the gaps, to help them progress through each phase,” he says.

Another major obstacle that Kawaguchi points out is the lack of funding given to some companies at Phase zero, especially those startups that don’t have a track record of successful venture capital raises.

“How do you get a track record if you’re not given an opportunity?” he posits. “The more we can support that Phase zero phase or Phase one research, the more shots on goal.

“And this is how we get more from the bench to the bedside – by supporting the front end of the pipeline.”

Continue Reading


Frequent Flyer Points: The Key to Confirmed Business Class Flights?



Increase of frequent flyer programs offered by airlines creates achievable and comfortable travel

It is becoming more apparent that the days of hoping for an upgrade when flying are gone.

With the increasing popularity of frequent flyer programs, more and more people are taking advantage of their accumulated points to secure confirmed business class flights.

The beauty of this trend is that it eliminates the risk of having to settle for a less comfortable economy class seat.

Flyers have found that they can redeem their points for business class tickets on a number of airlines, including some of the world’s most well-known carriers.

This allows them to enjoy the many benefits of a premium cabin, such as extra legroom, luxurious seating, and gourmet meals.

It also means that they can arrive at their destination refreshed and ready for business or leisure.

Steve Hui, also known as The Points Whisperer, is assisting his clients with his flight concierge service to help them turn their points into confirmed business class flights, by-passing the risk of hoping for an upgrade.

Continue Reading
Live Watch Ticker News Live

Trending Now

Copyright © 2023 The Ticker Company PTY LTD